NOVACLONE™ ANTI-C (RH4) HUMAN MONOCLONAL IGM RH TYPING REAGENTS - INVIMA Registration 2d7aee941c0b262e9284886e90afcf2b
Access comprehensive regulatory information for NOVACLONE™ ANTI-C (RH4) HUMAN MONOCLONAL IGM RH TYPING REAGENTS (NOVACLONE™ ANTI-C (RH4) HUMAN MONOCLONAL IGM RH TYPING REAGENTS) in the Colombia medical device market through Pure Global AI's free database. This III medical device is registered under INVIMA analysis ID 2d7aee941c0b262e9284886e90afcf2b and manufactured by IMMUCOR INC.. The device was registered on May 14, 2026.
This page provides complete registration details including product type (DIAGNOSTIC REAGENT), authorised information, and regulatory compliance data from the official Colombia INVIMA medical device database. Pure Global AI offers free access to Colombia's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate INVIMA regulations efficiently.
NOVACLONE ANTI-C (RH34) ESTÁ DESTINADO A LA _x000D_ DETECCIÓN DEL ANTÍGENO DEL GRUPO SANGUÍNEO RH C_x000D_ (RH4) EN LOS GLÓBULOS ROJOS HUMANOS. ESTE REACTIVO_x000D_ DE AGRUPACIÓN DE SANGRE ESTÁN DESTINADOS PARA SU_x000D_ USO EN PRUEBAS DE PORTAOBJETOS, TUBOS Y _x000D_ MICROPLACAS Y PROPORCIONAN UNA PRUEBA ESPECÍFICA _x000D_ Y CUALITATIVA PARA LA DETECCIÓN DEL ANTÍGENO RH _x000D_ CORRESPONDIENTE EN LOS GLÓBULOS ROJOS HUMANOS._x000D_
NOVACLONE ANTI-C (RH34) IS INTENDED FOR _x000D_ DETECTION OF RH BLOOD GROUP ANTIGEN C_x000D_ (RH4) IN HUMAN RED BLOOD CELLS. THIS REACTIVO_x000D_ BLOOD POOLING ARE INTENDED FOR SU_x000D_ USE IN SLIDE, TUBE AND _x000D_ TESTING MICROPLATES AND PROVIDE A SPECIFIC TEST _x000D_ AND QUALITATIVE FOR THE DETECTION OF RH ANTIGEN _x000D_ CORRESPONDING IN RED BLOOD CELLS HUMANOS._x000D_